Loading...

Siamak Daneshmand, MD

Title(s)Associate Professor of Urology (Clinical Scholar)
Phone+1 323 865 3700
vCardDownload vCard
    Other Positions
    Title(s)Director of Clinical Research


    Collapse Overview 
    Collapse Overview
    Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University where he established the Section of Urologic Oncology as a center of excellence for treatment of bladder and testis cancers. He was recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an associate professor of urology with clinical scholar designation and serves as director of clinical research as well as the urologic oncology fellowship director. Dr. Daneshmand’s main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience in urinary diversion and reconstruction following surgical removal of the bladder (radical cystectomy) as well as nerve-sparing retroperitoneal lymph node dissection (RPLND) following chemotherapy for advanced testis cancer. He is one of the highest volume surgeons for this disease on the west coast. He has been selected as one of “True Experts” in the Testicular Cancer Resource Center web site. He also has extensive experience in the management of advanced kidney cancers with vena caval tumor thrombus involvement, as well as prostate cancer, retroperitoneal sarcomas and surgeries requiring replacement of the great vessels. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Doctors” for several years. He is an active member of the Society of Urologic Oncology, has presented over 150 abstracts at scientific meetings and has authored over 120 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Websites
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lin-Brande M, Pearce SM, Ashrafi AN, Nazemi A, Burg ML, Ghodoussipour S, Miranda G, Djaladat H, Schuckman A, Daneshmand S. Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer. Urology. 2019 Aug 14. PMID: 31421144.
      View in: PubMed
    2. Barzi A, Lara PN, Tsao-Wei D, Yang D, Gill IS, Daneshmand S, Klein EA, Pinski JK, Penson DF, Quinn DI, Sadeghi S. Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy. Cancer. 2019 Aug 09. PMID: 31398279.
      View in: PubMed
    3. Daneshmand S. Preface. Urol Clin North Am. 2019 Aug; 46(3):xiii. PMID: 31277740.
      View in: PubMed
    4. Cheng KW, Shah A, Bazargani S, Miranda G, Cai J, Aron M, Schuckman A, Desai M, Gill I, Daneshmand S, Djaladat H. Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathway. Urol Oncol. 2019 Jul 17. PMID: 31326314.
      View in: PubMed
    5. Chen J, Djaladat H, Schuckman AK, Aron M, Desai M, Gill IS, Clifford TG, Ghodoussipour S, Miranda G, Cai J, Daneshmand S. Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field? Urol Oncol. 2019 Jul 05. PMID: 31285114.
      View in: PubMed
    6. Lotan Y, Bivalacqua TJ, Downs T, Huang W, Jones J, Kamat AM, Konety B, Malmström PU, McKiernan J, O'Donnell M, Patel S, Pohar K, Resnick M, Sankin A, Smith A, Steinberg G, Trabulsi E, Woods M, Daneshmand S. Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018. Nat Rev Urol. 2019 Jun; 16(6):377-386. PMID: 31019310.
      View in: PubMed
    7. Lotan Y, Inman BA, Davis LG, Kassouf W, Messing E, Daneshmand S, Canter D, Marble HT, Joseph AM, Jewell S, Boorjian SA. Evaluation of the UroVysion™ Test to Predict Recurrence and/or Progression of Disease After BCG for Primary High Grade Non-Muscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial. J Urol. 2019 May 23; 101097JU0000000000000355. PMID: 31120373.
      View in: PubMed
    8. Ghodoussipour S, Daneshmand S. Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor. Urol Clin North Am. 2019 Aug; 46(3):389-398. PMID: 31277733.
      View in: PubMed
    9. McAlpine K, Lavallée LT, Stacey D, Moodley P, Cagiannos I, Morash C, Black PC, Kulkarni GS, Shayegan B, Kassouf W, Siemens R, So A, Leveridge MJ, Boorjian SA, Daneshmand S, Smith AB, Power N, Izawa J, Drachenberg DE, Fairey A, Rendon RA, Breau RH. Development and acceptability testing of a patient decision aid for urinary diversion with radical cystectomy. J Urol. 2019 May 17; 101097JU0000000000000341. PMID: 31099720.
      View in: PubMed
    10. Konety B, Shore N, Kader AK, Porten S, Daneshmand S, Lough T, Lotan Y. Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy. Eur Urol. 2019 May 16. PMID: 31103391.
      View in: PubMed
    11. González J, Gaynor JJ, Martínez-Salamanca JI, Capitanio U, Tilki D, Carballido JA, Chantada V, Daneshmand S, Evans CP, Gasch C, Gontero P, Haferkamp A, Huang WC, Espinós EL, Master VA, McKiernan JM, Montorsi F, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vera-Donoso C, Zigeuner R, Hohenfellner M, Libertino JA, Ciancio G. Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. Eur J Surg Oncol. 2019 May 15. PMID: 31155470.
      View in: PubMed
    12. Chen J, Miranda G, Cai J, Daneshmand S, Djaladat H. Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy. Scand J Urol. 2019 Apr - Jun; 53(2-3):123-128. PMID: 31081431.
      View in: PubMed
    13. Nazemi A, Ghodoussipour S, Pearce S, Bhanvadia S, Daneshmand S. Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer. Urol Oncol. 2019 May 08. PMID: 31076355.
      View in: PubMed
    14. Stephenson A, Eggener SE, Bass EB, Chelnick DM, Daneshmand S, Feldman D, Gilligan T, Karam JA, Leibovich B, Liauw SL, Masterson TA, Meeks JJ, Pierorazio PM, Sharma R, Sheinfeld J. Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. J Urol. 2019 May 06; 101097JU0000000000000318. PMID: 31059667.
      View in: PubMed
    15. Burg ML, Daneshmand S. Frailty and preoperative risk assessment before radical cystectomy. Curr Opin Urol. 2019 May; 29(3):216-219. PMID: 30855379.
      View in: PubMed
    16. Batista da Costa J, Gibb EA, Bivalacqua TJ, Liu Y, Oo HZ, Miyamoto DT, Alshalalfa M, Davicioni E, Wright J, Dall'Era MA, Douglas J, Boormans JL, Van der Heijden MS, Wu CL, van Rhijn BWG, Gupta S, Grivas P, Mouw KW, Murugan P, Fazli L, Ra S, Konety BR, Seiler R, Daneshmand S, Mian OY, Efstathiou JA, Lotan Y, Black PC. Molecular Characterization of Neuroendocrine-like Bladder Cancer. Clin Cancer Res. 2019 Jul 01; 25(13):3908-3920. PMID: 30952638.
      View in: PubMed
    17. Pearce S, Daneshmand S. Correction to: Enhanced Endoscopy in Bladder Cancer. Curr Urol Rep. 2019 04 05; 20(5):25. PMID: 30953210.
      View in: PubMed
    18. Zainfeld D, Daneshmand S. Correction to: Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies. Curr Urol Rep. 2019 04 04; 20(5):24. PMID: 30949856.
      View in: PubMed
    19. Thaker H, Ghodoussipour S, Saffarian M, Ashrafi A, Miranda G, Cai J, Schuckman AK, Aron M, Desai M, Gill IS, Daneshmand S, Djaladat H. Extended hospital stay after radical cystectomy with enhanced recovery protocol. Can J Urol. 2019 Feb; 26(1):9654-9659. PMID: 30797248.
      View in: PubMed
    20. Amini E, Ahmadi N, Clifford TG, Hugen CM, Bazargani ST, Cai J, Miranda G, Sherrod AE, Daneshmand S, Djaladat H. Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy. Int Urol Nephrol. 2019 Mar; 51(3):435-441. PMID: 30706249.
      View in: PubMed
    21. Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, Aminorroaya A, Fitzmaurice C, Farzadfar F, Nowroozi MR, Black PC, Daneshmand S. Global, Regional, and National Burden of Bladder Cancer, 1990 - 2016: Results from the Global Burden of Disease Study 2016. J Urol. 2019 Jan 25. PMID: 30676477.
      View in: PubMed
    22. Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ, Sankin AI, Schoenberg MP, Shipley WU, Villers A, Efstathiou JA, Bellmunt J, Stenzl A. SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer. World J Urol. 2019 Jan; 37(1):61-83. PMID: 30684034.
      View in: PubMed
    23. Nazemi A, Nassiri N, Pearce S, Daneshmand S. Testicular Mesothelioma: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors. Urology. 2019 Apr; 126:140-144. PMID: 30668959.
      View in: PubMed
    24. Shah A, Nassiri N, Daneshmand S. Management of extraretroperitoneal masses in germ cell tumor. Curr Opin Urol. 2019 Jan; 29(1):33-41. PMID: 30334834.
      View in: PubMed
    25. Bateni ZH, Pearce SM, Zainfeld D, Ballas L, Djaladat H, Schuckman AK, Daneshmand S. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013. Eur Urol Oncol. 2018 Dec 19. PMID: 31317867.
      View in: PubMed
    26. Ghodoussipour S, Ahmadi N, Hartman N, Cacciamani G, Miranda G, Cai J, Schuckman A, Djaladat H, Gill I, Daneshmand S, Desai M. Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy. World J Urol. 2018 Dec 05. PMID: 30519743.
      View in: PubMed
    27. Lin-Brande M, Nazemi A, Pearce SM, Thompson ER, Ashrafi AN, Djaladat H, Schuckman A, Daneshmand S. Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States. Urol Oncol. 2019 Mar; 37(3):180.e1-180.e9. PMID: 30482434.
      View in: PubMed
    28. Bazargani ST, Clifford TG, Djaladat H, Schuckman AK, Wayne K, Miranda G, Cai J, Sadeghi S, Dorff T, Quinn DI, Daneshmand S. Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer. Urol Oncol. 2019 01; 37(1):1-11. PMID: 30470611.
      View in: PubMed
    29. Burg ML, Clifford TG, Bazargani ST, Lin-Brande M, Miranda G, Cai J, Schuckman AK, Djaladat H, Daneshmand S. Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments. Urol Oncol. 2019 01; 37(1):40-47. PMID: 30448327.
      View in: PubMed
    30. Zainfeld D, Chen J, Cai J, Miranda G, Schuckman A, Daneshmand S, Djaladat H. The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol. Ther Adv Urol. 2018 Dec; 10(12):393-401. PMID: 30574199.
      View in: PubMed
    31. Mitra AP, Fairey AS, Skinner EC, Boorjian SA, Frank I, Schoenberg MP, Bivalacqua TJ, Hyndman ME, Reese AC, Steinberg GD, Large MC, Hulsbergen-van de Kaa CA, Bruins HM, Daneshmand S. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. Urol Oncol. 2019 01; 37(1):48-56. PMID: 30446450.
      View in: PubMed
    32. Bhindi B, Abel EJ, Albiges L, Bensalah K, Boorjian SA, Daneshmand S, Karam JA, Mason RJ, Powles T, Bex A. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol. 2019 01; 75(1):111-128. PMID: 30467042.
      View in: PubMed
    33. García-Perdomo HA, Correa-Ochoa JJ, Contreras-García R, Daneshmand S. Effectiveness of extended pelvic lymphadenectomy in the survival of prostate cancer: a systematic review and meta-analysis. Cent European J Urol. 2018; 71(3):262-269. PMID: 30386645.
      View in: PubMed
    34. Pearce S, Daneshmand S. Enhanced Endoscopy in Bladder Cancer. Curr Urol Rep. 2018 Aug 17; 19(10):84. PMID: 30116985.
      View in: PubMed
    35. Williams SB, Hudgins HK, Ray-Zack MD, Chamie K, Smaldone MC, Boorjian SA, Daneshmand S, Black PC, Kamat AM, Goebell PJ, Seiler R, Schmitz-Drager B, Nawroth R, Baillargeon J, Klaassen Z, Kulkarni GS, Kim SP, Lee EK, Holzbeierlein JM, Hollenbeck BK, Gore JL. Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. Eur Urol Oncol. 2019 Mar; 2(2):119-125. PMID: 31017086.
      View in: PubMed
    36. Smith AB, Daneshmand S, Patel S, Pohar K, Trabulsi E, Woods M, Downs T, Huang W, Taylor J, Jones J, O'Donnell M, Bivalacqua T, DeCastro J, Steinberg G, Kamat A, Resnick M, Konety B, Schoenberg M, Jones JS, Lotan Y. Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study. BJU Int. 2019 Jan; 123(1):35-41. PMID: 29979488.
      View in: PubMed
    37. Ghodoussipour S, Daneshmand S. Current controversies on the role of lymphadenectomy for bladder cancer. Urol Oncol. 2019 Mar; 37(3):193-200. PMID: 29909945.
      View in: PubMed
    38. Bhanvadia S, Kazerouni K, Bazargani ST, Miranda G, Cai J, Daneshmand S, Djaladat H. Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy. World J Urol. 2019 Jan; 37(1):173-179. PMID: 29876671.
      View in: PubMed
    39. Daneshmand S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, Willard B, Taylor JM, Liao JC, Pohar K, Tierney J, Konety B. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. Urol Oncol. 2018 08; 36(8):361.e1-361.e6. PMID: 29859728.
      View in: PubMed
    40. Nassiri N, Shah A, Daneshmand S. Growing Teratoma Syndrome of Testicular Origin. Urology. 2019 Jan; 123:20-23. PMID: 29807046.
      View in: PubMed
    41. Marra G, Gontero P, Brattoli M, Filippini C, Capitanio U, Montorsi F, Daneshmand S, Huang WC, Linares Espinós E, Martínez-Salamanca JI, McKiernan JM, Zigeuner R, Libertino JA. Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort. Urol Oncol. 2018 Jul; 36(7):339.e1-339.e8. PMID: 29801993.
      View in: PubMed
    42. Lotan Y, Black PC, Caba L, Chang SS, Cookson MS, Daneshmand S, Kamat AM, McKiernan JM, Pruthi RS, Ritch CR, Steinberg GD, Svatek RS, Zwarthoff EC. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review. Eur Urol Oncol. 2018 Aug; 1(3):223-230. PMID: 31102625.
      View in: PubMed
    43. Zainfeld D, Shah A, Daneshmand S. Enhanced Recovery After Surgery Pathways: Role and Outcomes in the Management of Muscle Invasive Bladder Cancer. Urol Clin North Am. 2018 May; 45(2):229-239. PMID: 29650138.
      View in: PubMed
    44. Hussein AA, Sexton KJ, May PR, Meng MV, Hosseini A, Eun DD, Daneshmand S, Bochner BH, Peabody JO, Abaza R, Skinner EC, Hautmann RE, Guru KA. Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men. Surg Endosc. 2018 Nov; 32(11):4458-4464. PMID: 29654528.
      View in: PubMed
    45. Amini E, Palmer TC, Cai J, Lieskovsky G, Daneshmand S, Djaladat H. Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study. World J Urol. 2018 Aug; 36(8):1233-1239. PMID: 29536157.
      View in: PubMed
    46. Hu B, Daneshmand S. Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma. Adv Urol. 2018; 2018:7978958. PMID: 29487620.
      View in: PubMed
    47. Pearce SM, Daneshmand S. Continent Cutaneous Diversion. Urol Clin North Am. 2018 Feb; 45(1):55-65. PMID: 29169451.
      View in: PubMed
    48. Clifford TG, Katebian B, Van Horn CM, Bazargani ST, Cai J, Miranda G, Daneshmand S, Djaladat H. Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients. World J Urol. 2018 May; 36(5):775-781. PMID: 29372354.
      View in: PubMed
    49. Zargar H, Shah JB, van Rhijn BW, Daneshmand S, Bivalacqua TJ, Spiess PE, Black PC, Kassouf W. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy. J Urol. 2018 Jun; 199(6):1452-1458. PMID: 29329894.
      View in: PubMed
    50. Bazargani ST, Ghodoussipour S, Tse B, Miranda G, Cai J, Schuckman A, Daneshmand S, Djaladat H. The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol. World J Urol. 2018 Mar; 36(3):401-407. PMID: 29299662.
      View in: PubMed
    51. Mitra AP, Daneshmand S. Molecular Prognostication in Bladder Cancer. Cancer Treat Res. 2018; 175:165-191. PMID: 30168122.
      View in: PubMed
    52. Chen J, Daneshmand S. Modern Management of Testicular Cancer. Cancer Treat Res. 2018; 175:273-308. PMID: 30168127.
      View in: PubMed
    53. Clifford TG, Burg ML, Hu B, Loh-Doyle J, Hugen CM, Cai J, Djaladat H, Wayne K, Daneshmand S. Satisfaction With Testicular Prosthesis After Radical Orchiectomy. Urology. 2018 Apr; 114:128-132. PMID: 29288790.
      View in: PubMed
    54. Daneshmand S, Patel S, Lotan Y, Pohar K, Trabulsi E, Woods M, Downs T, Huang W, Jones J, O'Donnell M, Bivalacqua T, DeCastro J, Steinberg G, Kamat A, Resnick M, Konety B, Schoenberg M, Jones JS. Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study. J Urol. 2018 May; 199(5):1158-1165. PMID: 29203268.
      View in: PubMed
    55. Loh-Doyle J, Bhanvadia S, Patil MB, Djaladat H, Daneshmand S. Vena Cavoscopy in the Assessment of Intraluminal Vena Caval Tumor Involvement. Urology. 2018 Mar; 113:105-109. PMID: 29191641.
      View in: PubMed
    56. Tilki D, Chandrasekar T, Capitanio U, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Linares Espinós E, Lorentz A, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vera-Donoso C, Zigeuner R, Libertino JA, Evans CP. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Urol Oncol. 2018 02; 36(2):79.e11-79.e17. PMID: 29129353.
      View in: PubMed
    57. Abufaraj M, Dalbagni G, Daneshmand S, Horenblas S, Kamat AM, Kanzaki R, Zlotta AR, Shariat SF. The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review. Eur Urol. 2018 04; 73(4):543-557. PMID: 29122377.
      View in: PubMed
    58. Gakis G, Schubert T, Morgan TM, Daneshmand S, Keegan KA, Mischinger J, Clayman RH, Brisuda A, Ali-El-Dein B, Galland S, Gregg J, Balci M, Olugbade K, Rink M, Fritsche HM, Burger M, Babjuk M, Stenzl A, Thalmann GN, Kübler H, Efstathiou JA. The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urol Oncol. 2018 01; 36(1):10.e7-10.e14. PMID: 29055518.
      View in: PubMed
    59. Goldenberg MG, Nabhani J, Wallis CJD, Chopra S, Hung AJ, Schuckman A, Djaladat H, Daneshmand S, Desai MM, Aron M, Gill IS, Satkunasivam R. Feasibility of expert and crowd-sourced review of intraoperative video for quality improvement of intracorporeal urinary diversion during robotic radical cystectomy. Can Urol Assoc J. 2017 Oct; 11(10):331-336. PMID: 29382445.
      View in: PubMed
    60. Loh JM, Tran AL, Ji L, Groshen S, Daneshmand S, Schuckman A, Quinn DI, Dorff TB. Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients. Clin Genitourin Cancer. 2017 Sep 06. PMID: 28958673.
      View in: PubMed
    61. Tandstad T, Kollmannsberger CK, Roth BJ, Jeldres C, Gillessen S, Fizazi K, Daneshmand S, Lowrance WT, Hanna NH, Albany C, Foster R, Cedermark GC, Feldman DR, Powles T, Lewis MA, Grimison PS, Bank D, Porter C, Albers P, De Santis M, Srinivas S, Bosl GJ, Nichols CR. Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm. J Clin Oncol. 2017 Nov 01; 35(31):3525-3528. PMID: 28854068.
      View in: PubMed
    62. Zargar H, Shah JB, van de Putte EEF, Potvin KR, Zargar-Shoshtari K, van Rhijn BW, Daneshmand S, Holzbeierlein JM, Spiess PE, Winquist E, Horenblas S, Dinney C, Black PC, Kassouf W. Dose dense MVAC prior to radical cystectomy: a real-world experience. World J Urol. 2017 Nov; 35(11):1729-1736. PMID: 28625005.
      View in: PubMed
    63. Haddad AQ, Hutchinson R, Wood EL, Miranda G, Gershman B, Messer J, Svatek R, Black PC, Boorjian SA, Shah J, Daneshmand S, Lotan Y. Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional Study. Clin Genitourin Cancer. 2017 12; 15(6):689-695.e2. PMID: 28558988.
      View in: PubMed
    64. Ballas L, Sargos P, Orré M, Bian SX, Daneshmand S, Eapen LJ. Tolerance of Orthotopic Ileal Neobladders to Radiotherapy: A Multi-institutional Retrospective Study. Clin Genitourin Cancer. 2017 12; 15(6):711-716. PMID: 28558986.
      View in: PubMed
    65. Syan-Bhanvadia S, Drangsholt S, Shah S, Cai J, Miranda G, Djaladat H, Daneshmand S. Restrictive transfusion in radical cystectomy is safe. Urol Oncol. 2017 08; 35(8):528.e15-528.e21. PMID: 28476526.
      View in: PubMed
    66. Zainfeld D, Daneshmand S. Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies. Curr Urol Rep. 2017 May; 18(5):34. PMID: 28283914.
      View in: PubMed
    67. Bazargani ST, Djaladat H, Ahmadi H, Miranda G, Cai J, Schuckman AK, Daneshmand S. Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol. Eur Urol Focus. 2018 12; 4(6):889-894. PMID: 28753885.
      View in: PubMed
    68. Syan-Bhanvadia S, Bazargani ST, Clifford TG, Cai J, Miranda G, Daneshmand S. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity. Eur Urol. 2017 11; 72(5):814-820. PMID: 28325537.
      View in: PubMed
    69. Barzi A, Klein EA, Daneshmand S, Gill I, Quinn DI, Sadeghi S. Access to high-volume surgeons and the opportunity cost of performing radical prostatectomy by low-volume providers. Urol Oncol. 2017 07; 35(7):459.e15-459.e24. PMID: 28284890.
      View in: PubMed
    70. McGrath JS, Daneshmand S. Readmission Following Radical Cystectomy: A Ray of Light in the "Black Box"? Eur Urol Focus. 2018 09; 4(5):718-719. PMID: 28753859.
      View in: PubMed
    71. Djaladat H, Amini E, Xu W, Cai J, Daneshmand S, Lieskovsky G. Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases. Prostate. 2017 May; 77(7):743-748. PMID: 28144967.
      View in: PubMed
    72. Moschini M, Morlacco A, Briganti A, Hu B, Colombo R, Montorsi F, Frank I, Daneshmand S, Karnes RJ. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy. Eur Urol Focus. 2018 03; 4(2):245-251. PMID: 28753820.
      View in: PubMed
    73. Djaladat H, Katebian B, Bazargani ST, Miranda G, Cai J, Schuckman AK, Daneshmand S. 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study. World J Urol. 2017 Jun; 35(6):907-911. PMID: 27734131.
      View in: PubMed
    74. Wymer KM, Pearce SM, Harris KT, Pierorazio PM, Daneshmand S, Eggener SE. Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer. J Urol. 2017 03; 197(3 Pt 1):684-689. PMID: 27663460.
      View in: PubMed
    75. Hugen CM, Duddalwar V, Daneshmand S. Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy. Curr Urol Rep. 2016 Sep; 17(9):62. PMID: 27432379.
      View in: PubMed
    76. Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA, McKiernan JM, Libertino JA, Haferkamp A, Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Hohenfellner M, Huang WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A, Martínez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, O'Malley P, Pahernik S, Palou J, Moreno JL, Pruthi RS, Faba OR, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Tilki D, Vázquez-Martul D, Donoso CV, Vergho D, Wallen EM, Zigeuner R. Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival. J Surg Oncol. 2016 Nov; 114(6):764-768. PMID: 27562252.
      View in: PubMed
    77. Gakis G, Efstathiou JA, Daneshmand S, Keegan KA, Clayman RH, Hrbacek J, Ali-El-Dein B, Zaid HB, Schubert T, Mischinger J, Todenhöfer T, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Morgan TM. Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urol Int. 2016; 97(2):134-41. PMID: 27462702.
      View in: PubMed
    78. Zhang Y, Shamie N, Daneshmand S. Assessment of Urologists' Knowledge of Intraoperative Floppy Iris Syndrome. Urology. 2016 11; 97:40-45. PMID: 27453216.
      View in: PubMed
    79. Djaladat H, Daneshmand S. Gastrointestinal Complications in Patients Who Undergo Radical Cystectomy with Enhanced Recovery Protocol. Curr Urol Rep. 2016 Jul; 17(7):50. PMID: 27125653.
      View in: PubMed
    80. Hugen CM, Hu B, Jeldres C, Burton C, Nichols CR, Porter CR, Daneshmand S. Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011). Urol Oncol. 2016 11; 34(11):487.e7-487.e11. PMID: 27372281.
      View in: PubMed
    81. Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, Pruthi R, Quale DZ, Ritch CR, Seigne JD, Skinner EC, Smith ND, McKiernan JM. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. J Urol. 2016 Oct; 196(4):1021-9. PMID: 27317986.
      View in: PubMed
    82. Duivenvoorden WC, Daneshmand S, Canter D, Lotan Y, Black PC, Abdi H, van Rhijn BW, Fransen van de Putte EE, Zareba P, Koskinen I, Kassouf W, Traboulsi SL, Kukreja JE, Boström PJ, Shayegan B, Pinthus JH. Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy. J Urol. 2016 12; 196(6):1627-1633. PMID: 27312316.
      View in: PubMed
    83. Shahabi A, Lewinger JP, Ren J, April C, Sherrod AE, Hacia JG, Daneshmand S, Gill I, Pinski JK, Fan JB, Stern MC. Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients. Prostate. 2016 10; 76(14):1239-56. PMID: 27272349.
      View in: PubMed
    84. Clifford TG, Shah SH, Bazargani ST, Miranda G, Cai J, Wayne K, Djaladat H, Schuckman AK, Daneshmand S. Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire. J Urol. 2016 12; 196(6):1685-1691. PMID: 27256205.
      View in: PubMed
    85. Feldman DR, Hu J, Dorff TB, Lim K, Patil S, Woo KM, Carousso M, Hughes A, Sheinfeld J, Bains M, Daneshmand S, Ketchens C, Bajorin DF, Bosl GJ, Quinn DI, Motzer RJ. Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors. J Clin Oncol. 2016 07 20; 34(21):2478-83. PMID: 27185842.
      View in: PubMed
    86. Seiler R, Lam LL, Erho N, Takhar M, Mitra AP, Buerki C, Davicioni E, Skinner EC, Daneshmand S, Black PC. Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures. J Urol. 2016 Oct; 196(4):1036-41. PMID: 27105761.
      View in: PubMed
    87. Daneshmand S. Editorial Comment. J Urol. 2016 06; 195(6):1716. PMID: 27015972.
      View in: PubMed
    88. Gakis G, Schubert T, Alemozaffar M, Bellmunt J, Bochner BH, Boorjian SA, Daneshmand S, Huang WC, Kondo T, Konety BR, Laguna MP, Matin SF, Siefker-Radtke AO, Shariat SF, Stenzl A. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. World J Urol. 2017 Mar; 35(3):327-335. PMID: 27043218.
      View in: PubMed
    89. Movassaghi K, Shah SH, Cai J, Miranda G, Fernandez J, Duddalwar V, Daneshmand S, Djaladat H. Incisional and Parastomal Hernia following Radical Cystectomy and Urinary Diversion: The University of Southern California Experience. J Urol. 2016 Sep; 196(3):777-81. PMID: 27044570.
      View in: PubMed
    90. Shahabi A, Satkunasivam R, Gill IS, Lieskovsky G, Daneshmand S, Pinski JK, Stern MC. Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era. Can Urol Assoc J. 2016 Jan-Feb; 10(1-2):E17-22. PMID: 26858782.
      View in: PubMed
    91. Hugen CM, Daneshmand S. Lymph node dissection in bladder cancer: Where do we stand? World J Urol. 2017 Apr; 35(4):527-533. PMID: 26712616.
      View in: PubMed
    92. Daneshmand S. Orthotopic urinary diversion. Curr Opin Urol. 2015 Nov; 25(6):545-9. PMID: 26414610.
      View in: PubMed
    93. Daneshmand S. Urinary diversion 2015: controversies and new technologies: Choosing the 'right' diversion. Curr Opin Urol. 2015 Nov; 25(6):543-4. PMID: 26414606.
      View in: PubMed
    94. Zargar H, Zargar-Shoshtari K, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black P. Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1? J Urol. 2016 Apr; 195(4 Pt 1):886-93. PMID: 26521718.
      View in: PubMed
    95. Hugen CM, Daneshmand S. Orthotopic urinary diversion in the elderly. World J Urol. 2016 Jan; 34(1):13-8. PMID: 26410825.
      View in: PubMed
    96. Hahn NM, Knudsen BS, Daneshmand S, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Liu Z, Breen T, Fleming MT, Lance R, Corless CL, Alva AS, Shen SS, Huang F, Gertych A, Gallick GE, Mallick J, Ryan C, Galsky MD, Lerner SP, Posadas EM, Sonpavde G. Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity. Urol Oncol. 2016 Jan; 34(1):4.e11-7. PMID: 26362343.
      View in: PubMed
    97. Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol. 2016 Feb; 69(2):300-10. PMID: 26346676.
      View in: PubMed
    98. Xu W, Daneshmand S, Bazargani ST, Cai J, Miranda G, Schuckman AK, Djaladat H. Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway. J Urol. 2015 Nov; 194(5):1209-13. PMID: 26021824.
      View in: PubMed
    99. Zargar-Shoshtari K, Zargar H, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy. J Urol. 2016 Jan; 195(1):53-9. PMID: 26205531.
      View in: PubMed
    100. Satkunasivam R, Santomauro M, Chopra S, Plotner E, Cai J, Miranda G, Salibian S, Aron M, Ginsberg D, Daneshmand S, Desai M, Gill IS. Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life. Eur Urol. 2016 Feb; 69(2):247-53. PMID: 26164417.
      View in: PubMed
    101. Nabhani J, Ahmadi H, Schuckman AK, Cai J, Miranda G, Djaladat H, Daneshmand S. Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer. Eur Urol Focus. 2016 Apr; 2(1):92-96. PMID: 28723457.
      View in: PubMed
    102. Zehnder P, Moltzahn F, Mitra AP, Cai J, Miranda G, Skinner EC, Gill IS, Daneshmand S. Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes. BJU Int. 2016 Feb; 117(2):253-9. PMID: 25307941.
      View in: PubMed
    103. Hu B, Daneshmand S. Role of Extraretroperitoneal Surgery in Patients with Metastatic Germ Cell Tumors. Urol Clin North Am. 2015 Aug; 42(3):369-80. PMID: 26216824.
      View in: PubMed
    104. Satkunasivam R, Hu B, Daneshmand S. Is frozen section analysis of ureteral margins at time of radical cystectomy useful? Curr Urol Rep. 2015 Jun; 16(6):38. PMID: 25940187.
      View in: PubMed
    105. Gakis G, Morgan TM, Efstathiou JA, Keegan KA, Mischinger J, Todenhoefer T, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Daneshmand S. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol. 2016 Jan; 34(1):97-103. PMID: 25981402.
      View in: PubMed
    106. Shah SH, Movassaghi K, Skinner D, Dalag L, Miranda G, Cai J, Schuckman A, Daneshmand S, Djaladat H. Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience. Urology. 2015 Jul; 86(1):87-91. PMID: 25987494.
      View in: PubMed
    107. Satkunasivam R, Hu B, Metcalfe C, Ghodoussipour SB, Aron M, Cai J, Miranda G, Gill I, Daneshmand S. Utility and significance of ureteric frozen section analysis during radical cystectomy. BJU Int. 2016 Mar; 117(3):463-8. PMID: 25684323.
      View in: PubMed
    108. Daneshmand S. Role of surgical resection for refractory germ cell tumors. Urol Oncol. 2015 Aug; 33(8):370-8. PMID: 25858101.
      View in: PubMed
    109. Skinner EC, Fairey AS, Groshen S, Daneshmand S, Cai J, Miranda G, Skinner DG. Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Patients with Bladder Cancer. J Urol. 2015 Aug; 194(2):433-9. PMID: 25823791.
      View in: PubMed
    110. Nguyen HG, Tilki D, Dall'Era MA, Durbin-Johnson B, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Espinós EL, Mandel P, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. J Urol. 2015 Aug; 194(2):304-308. PMID: 25797392; PMCID: PMC5012645.
    111. Niver BE, Daneshmand S, Satkunasivam R. Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes. Curr Opin Urol. 2015 Mar; 25(2):105-10. PMID: 25581538.
      View in: PubMed
    112. Hu B, Shah S, Shojaei S, Daneshmand S. Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma. Clin Genitourin Cancer. 2015 Aug; 13(4):e265-e269. PMID: 25682512.
      View in: PubMed
    113. Hu B, Satkunasivam R, Schuckman A, Miranda G, Cai J, Daneshmand S. Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy. World J Urol. 2015 Oct; 33(10):1397-402. PMID: 25549760.
      View in: PubMed
    114. Simone G, Bianchi M, Giannarelli D, Daneshmand S, Papalia R, Ferriero M, Guaglianone S, Sentinelli S, Colombo R, Montorsi F, Collura D, Muto G, Novara G, Hurle R, Rink M, Fisch M, Abol-Enein H, Miranda G, Desai M, Gill I, Gallucci M. Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy. World J Urol. 2015 Oct; 33(10):1419-28. PMID: 25542395.
      View in: PubMed
    115. Vashistha V, Quinn DI, Dorff TB, Daneshmand S. Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review. BMC Cancer. 2014 Dec 16; 14:966. PMID: 25515347.
      View in: PubMed
    116. Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Buerki C, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer. J Natl Cancer Inst. 2014 Nov; 106(11). PMID: 25344601.
      View in: PubMed
    117. Mitra AP, Alemozaffar M, Harris BN, Schuckman AK, Skinner EC, Daneshmand S. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Urology. 2014 Dec; 84(6):1420-6. PMID: 25306479.
      View in: PubMed
    118. Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2015 Feb; 67(2):241-9. PMID: 25257030.
      View in: PubMed
    119. Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10):589-96. PMID: 25245244.
      View in: PubMed
    120. Hu B, Satkunasivam R, Schuckman A, Sherrod A, Cai J, Miranda G, Daneshmand S. Significance of perivesical lymph nodes in radical cystectomy for bladder cancer. Urol Oncol. 2014 Nov; 32(8):1158-65. PMID: 25238701.
      View in: PubMed
    121. Sun AJ, Djaladat H, Schuckman A, Miranda G, Cai J, Daneshmand S. Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. J Urol. 2015 Feb; 193(2):565-9. PMID: 25150642.
      View in: PubMed
    122. Kollmannsberger C, Tandstad T, Bedard PL, Cohn-Cedermark G, Chung PW, Jewett MA, Powles T, Warde PR, Daneshmand S, Protheroe A, Tyldesley S, Black PC, Chi K, So AI, Moore MJ, Nichols CR. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol. 2015 Jan 01; 33(1):51-7. PMID: 25135991.
      View in: PubMed
    123. Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. J Urol. 2015 Feb; 193(2):436-42. PMID: 25063493.
      View in: PubMed
    124. Ahmadi H, Daneshmand S. Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes. Patient Relat Outcome Meas. 2014; 5:63-70. PMID: 25045284.
      View in: PubMed
    125. Faber KD, Carlos MC, Cortessis VK, Daneshmand S. Validation of Surveillance, Epidemiology, and End Results TNM staging for testicular germ cell tumor. Urol Oncol. 2014 Nov; 32(8):1341-6. PMID: 24856980.
      View in: PubMed
    126. Lee DJ, Djaladat H, Tadros NN, Movassaghi M, Tejura T, Duddalwar V, Daneshmand S. Growing teratoma syndrome: clinical and radiographic characteristics. Int J Urol. 2014 Sep; 21(9):905-8. PMID: 24750260.
      View in: PubMed
    127. Patil MB, Montez J, Loh-Doyle J, Cai J, Skinner EC, Schuckman A, Thangathurai D, Skinner DG, Daneshmand S. Level III-IV inferior vena caval thrombectomy without cardiopulmonary bypass: long-term experience with intrapericardial control. J Urol. 2014 Sep; 192(3):682-8. PMID: 24704114.
      View in: PubMed
    128. Su SF, de Castro Abreu AL, Chihara Y, Tsai Y, Andreu-Vieyra C, Daneshmand S, Skinner EC, Jones PA, Siegmund KD, Liang G. A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrence. Clin Cancer Res. 2014 Apr 01; 20(7):1978-89. PMID: 24691641.
      View in: PubMed
    129. Ahmadi H, Djaladat H, Cai J, Miranda G, Daneshmand S. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder. Urol Oncol. 2014 Jul; 32(5):648-56. PMID: 24680660.
      View in: PubMed
    130. Djaladat H, Daneshmand S. Enhanced recovery pathway following radical cystectomy. Curr Opin Urol. 2014 Mar; 24(2):135-9. PMID: 24378979.
      View in: PubMed
    131. Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rödel CM, Shariat SF, Shipley WU, Sternberg CN, Thalmann GN, Kassouf W. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol. 2014 Jul; 66(1):120-37. PMID: 24613684.
      View in: PubMed
    132. Lay FD, Triche TJ, Tsai YC, Su SF, Martin SE, Daneshmand S, Skinner EC, Liang G, Chihara Y, Jones PA. Reprogramming of the human intestinal epigenome by surgical tissue transposition. Genome Res. 2014 Apr; 24(4):545-53. PMID: 24515120.
      View in: PubMed
    133. Daneshmand S, Ahmadi H, Schuckman AK, Mitra AP, Cai J, Miranda G, Djaladat H. Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol. 2014 Jul; 192(1):50-5. PMID: 24518775.
      View in: PubMed
    134. Zehnder P, Studer UE, Daneshmand S, Birkhäuser FD, Skinner EC, Roth B, Miranda G, Burkhard FC, Cai J, Skinner DG, Thalmann GN, Gill IS. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU Int. 2014 Apr; 113(4):554-60. PMID: 24131453.
      View in: PubMed
    135. Djaladat H, Movassaghi K, Ahmadi H, Nichols CR, Daneshmand S. Mesenteric lymphadenopathy in testicular germ cell tumor. Urology. 2014 Mar; 83(3):e7-8. PMID: 24418390.
      View in: PubMed
    136. Lee RK, Abol-Enein H, Artibani W, Bochner B, Dalbagni G, Daneshmand S, Fradet Y, Hautmann RE, Lee CT, Lerner SP, Pycha A, Sievert KD, Stenzl A, Thalmann G, Shariat SF. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int. 2014 Jan; 113(1):11-23. PMID: 24330062.
      View in: PubMed
    137. Xylinas E, Kluth LA, Lotan Y, Daneshmand S, Rieken M, Karakiewicz PI, Shariat SF. Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder. Urol Oncol. 2014 Apr; 32(3):230-42. PMID: 24332648.
      View in: PubMed
    138. Bartsch G, Daneshmand S, Skinner EC, Syan S, Skinner DG, Penson DF. Urinary functional outcomes in female neobladder patients. World J Urol. 2014 Feb; 32(1):221-8. PMID: 24317553.
      View in: PubMed
    139. Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urol Oncol. 2014 Jan; 32(1):52.e1-9. PMID: 24239476.
      View in: PubMed
    140. Fairey AS, Daneshmand S, Skinner EC, Schuckman A, Cai J, Lieskovsky G. Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. Urol Oncol. 2014 Feb; 32(2):85-91. PMID: 24183191.
      View in: PubMed
    141. Daneshmand S. Editorial comment. Urology. 2013 Dec; 82(6):1346. PMID: 24094653.
      View in: PubMed
    142. Nichols CR, Roth B, Albers P, Einhorn LH, Foster R, Daneshmand S, Jewett M, Warde P, Sweeney CJ, Beard C, Powles T, Tyldesley S, So A, Porter C, Olgac S, Fizazi K, Hayes-Lattin B, Grimison P, Toner G, Cathomas R, Bokemeyer C, Kollmannsberger C. Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol. 2013 Oct 01; 31(28):3490-3. PMID: 24002502.
      View in: PubMed
    143. Zehnder P, Moltzahn F, Daneshmand S, Leahy M, Cai J, Miranda G, Bartsch G, Mitra AP, Skinner DG, Skinner EC, Gill IS. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy. BJU Int. 2014 Jan; 113(1):65-9. PMID: 23937628.
      View in: PubMed
    144. Thomas JP, Davis-Dao C, Lewinger JP, Siegmund KD, Hamilton AS, Daneshmand S, Skinner EC, Thomas DC, Cortessis VK. Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors. Am J Epidemiol. 2013 Oct 15; 178(8):1240-5. PMID: 23928263.
      View in: PubMed
    145. Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol. 2014 Jan; 191(1):40-7. PMID: 23911605.
      View in: PubMed
    146. Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S. The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU Int. 2014 Jun; 113(6):887-93. PMID: 23906037.
      View in: PubMed
    147. Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. Eur Urol. 2014 Sep; 66(3):577-83. PMID: 23871402.
      View in: PubMed
    148. Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B, Cai J, Birkhäuser FD, Mitra AP, Burkhard FC, Dorin RP, Daneshmand S, Skinner DG, Gill IS. Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int. 2013 Jul; 112(2):E51-8. PMID: 23795798.
      View in: PubMed
    149. Daneshmand S. Editorial comment. J Urol. 2013 Sep; 190(3):927. PMID: 23770495.
      View in: PubMed
    150. Bruins HM, Djaladat H, Ahmadi H, Sherrod A, Cai J, Miranda G, Skinner EC, Daneshmand S. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens. J Urol. 2013 Nov; 190(5):1704-9. PMID: 23707451.
      View in: PubMed
    151. Djaladat H, Mitra AP, Miranda G, Skinner EC, Daneshmand S. Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: oncological outcomes. Int J Urol. 2013 Dec; 20(12):1229-33. PMID: 23521752.
      View in: PubMed
    152. Fairey AS, Daneshmand S, Wang L, Schuckman A, Lieskovsky G, Djaladat H, Cai J, Miranda G, Skinner EC. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urol Oncol. 2014 Feb; 32(2):110-6. PMID: 23499168.
      View in: PubMed
    153. Daneshmand S, Ahmadi H. Conversion from incontinent conduit to continent cutaneous reservoir after renal transplant. Urology. 2013 May; 81(5):1086-9. PMID: 23490526.
      View in: PubMed
    154. Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol. 2014 Feb; 32(2):117-27. PMID: 23477878.
      View in: PubMed
    155. Banks K, Tuazon E, Berhane K, Koh CJ, De Filippo RE, Chang A, Kim SS, Daneshmand S, Davis-Dao C, Lewinger JP, Bernstein L, Cortessis VK. Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics. Front Endocrinol (Lausanne). 2012; 3:182. PMID: 23423470.
      View in: PubMed
    156. Daneshmand S. Determining the role of cystectomy for high-grade T1 urothelial carcinoma. Urol Clin North Am. 2013 May; 40(2):233-47. PMID: 23540781.
      View in: PubMed
    157. Bruins HM, Skinner EC, Dorin RP, Ahmadi H, Djaladat H, Miranda G, Cai J, Daneshmand S. Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study. Urol Oncol. 2014 Jan; 32(1):24.e13-9. PMID: 23395238.
      View in: PubMed
    158. Ahmadi H, Daneshmand S. Androgen deprivation therapy: evidence-based management of side effects. BJU Int. 2013 Apr; 111(4):543-8. PMID: 23351025.
      View in: PubMed
    159. Daneshmand S. Editorial comment. J Urol. 2013 Apr; 189(4):1318-9. PMID: 23333612.
      View in: PubMed
    160. Ahmadi H, Skinner EC, Simma-Chiang V, Miranda G, Cai J, Penson DF, Daneshmand S. Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients. J Urol. 2013 May; 189(5):1782-8. PMID: 23159582.
      View in: PubMed
    161. Daneshmand S, Gill IS. Minimally invasive postchemotherapy retroperitoneal lymph node dissection: caution and prudence. Eur Urol. 2013 Jun; 63(6):1018-9; discussion 1020. PMID: 23158589.
      View in: PubMed
    162. Fairey AS, Daneshmand S, Quinn D, Dorff T, Dorin R, Lieskovsky G, Schuckman A, Cai J, Miranda G, Skinner EC. Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. Urol Oncol. 2013 Nov; 31(8):1737-43. PMID: 23141776.
      View in: PubMed
    163. Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S. Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer. J Urol. 2012 Dec; 188(6):2134-8. PMID: 23083874.
      View in: PubMed
    164. Ahmadi H, Mitra AP, Abdelsayed GA, Cai J, Djaladat H, Bruins HM, Daneshmand S. Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer. BJU Int. 2013 Apr; 111(4 Pt B):E167-72. PMID: 23035696.
      View in: PubMed
    165. Daneshmand S, Ahmadi H, Huynh LN, Dobos N. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology. 2012 Dec; 80(6):1313-8. PMID: 23040723.
      View in: PubMed
    166. Bruins HM, Wopat R, Mitra AP, Cai J, Miranda G, Skinner EC, Daneshmand S. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU Int. 2013 Mar; 111(3 Pt B):E37-42. PMID: 22974410.
      View in: PubMed
    167. Mitra AP, Skinner EC, Miranda G, Daneshmand S. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. BJU Int. 2013 Feb; 111(2):240-8. PMID: 22928881.
      View in: PubMed
    168. Kim P, Syan-Bhanvadia S, Djaladat H, Faber K, Tadros NN, Nichols C, Daneshmand S. Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor. Urology. 2012 Oct; 80(4):941-5. PMID: 22951007.
      View in: PubMed
    169. Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L. Contemporary management of postchemotherapy testis cancer. Eur Urol. 2012 Nov; 62(5):867-76. PMID: 22938868.
      View in: PubMed
    170. Goh AC, Gill IS, Lee DJ, de Castro Abreu AL, Fairey AS, Leslie S, Berger AK, Daneshmand S, Sotelo R, Gill KS, Xie HW, Chu LY, Aron M, Desai MM. Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles. Eur Urol. 2012 Nov; 62(5):891-901. PMID: 22920581.
      View in: PubMed
    171. Rink M, Shariat SF, Xylinas E, Fitzgerald JP, Hansen J, Green DA, Kamat AM, Novara G, Daneshmand S, Fradet Y, Tagawa ST, Bastian PJ, Kassouf W, Trinh QD, Karakiewicz PI, Fritsche HM, Tilki D, Chun FK, Volkmer BG, Babjuk M, Merseburger AS, Scherr DS, Lotan Y, Svatek RS. Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol. 2012 Dec; 30(6):807-14. PMID: 22832587.
      View in: PubMed
    172. Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Eur Urol. 2013 Nov; 64(5):837-45. PMID: 22877503.
      View in: PubMed
    173. Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int. 2013 Jan; 111(1):74-84. PMID: 22809039.
      View in: PubMed
    174. Daneshmand S. Editorial comment. Urology. 2012 Sep; 80(3):639; author reply 639-40. PMID: 22795378.
      View in: PubMed
    175. Suriano F, Daneshmand S, Buscarini M. Use of nonabsorbable staples for urinary diversion: a step in the wrong direction. Urol Int. 2013; 90(2):125-9. PMID: 22777143.
      View in: PubMed
    176. Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU Int. 2013 Feb; 111(2):249-55. PMID: 22727036.
      View in: PubMed
    177. Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Eur Urol. 2013 Feb; 63(2):371-8. PMID: 22727174.
      View in: PubMed
    178. Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, Hahn NM, Lerner SP, Mason M, Powles T, Sternberg CN, Sonpavde G. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2012 Sep; 62(3):523-33. PMID: 22677572.
      View in: PubMed
    179. Bruins HM, Dorin RP, Rubino B, Miranda G, Cai J, Daneshmand S, Skinner EC. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy. Eur Urol. 2012 Oct; 62(4):671-6. PMID: 22575915.
      View in: PubMed
    180. Dorin RP, Lieskovsky G, Fairey AS, Cai J, Daneshmand S. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era. Urol Oncol. 2013 Nov; 31(8):1441-7. PMID: 22516714.
      View in: PubMed
    181. Daneshmand S. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. BJU Int. 2012 Nov; 110(9):1324. PMID: 22500693.
      View in: PubMed
    182. Huang EY, Skinner EC, Boyd SD, Cai J, Miranda G, Daneshmand S. Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy. World J Urol. 2012 Dec; 30(6):741-5. PMID: 22457033.
      View in: PubMed
    183. Djaladat H, Nichols C, Daneshmand S. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Ann Surg Oncol. 2012 Jul; 19(7):2388-93. PMID: 22395993.
      View in: PubMed
    184. Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol. 2012 Oct; 62(4):677-84. PMID: 22349570.
      View in: PubMed
    185. Daneshmand S. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer. BJU Int. 2012 Jul; 110(2 Pt 2):E80. PMID: 22313808.
      View in: PubMed
    186. Daneshmand S. Editorial comment. Urology. 2012 Feb; 79(2):481; author reply 481-2. PMID: 22310767.
      View in: PubMed
    187. Dorin RP, Daneshmand S, Lassoff MA, Cai J, Skinner DG, Lieskovsky G. Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era. Urology. 2012 Mar; 79(3):626-31. PMID: 22245303.
      View in: PubMed
    188. Djaladat H, Nichols CR, Daneshmand S. Chemoresponsive liver hemangioma in a patient with a metastatic germ cell tumor. J Clin Oncol. 2011 Dec 10; 29(35):e842-4. PMID: 22067396.
      View in: PubMed
    189. Daneshmand S, Stephenson AJ, Sheinfeld J, Jewett MA. The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation. Urol Oncol. 2011 Nov-Dec; 29(6):842-7. PMID: 22078409.
      View in: PubMed
    190. Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol. 2012 Feb; 61(2):237-42. PMID: 22033174.
      View in: PubMed
    191. Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, Miranda G, Birkhäuser F, Stein J, Burkhard FC, Daneshmand S, Thalmann GN, Gill IS, Skinner DG. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011 Oct; 186(4):1261-8. PMID: 21849183.
      View in: PubMed
    192. Mitra AP, Quinn DI, Dorff TB, Skinner EC, Schuckman AK, Miranda G, Gill IS, Daneshmand S. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int. 2012 Mar; 109(6):846-54. PMID: 21812902.
      View in: PubMed
    193. Daneshmand S, Djaladat H, Nichols C. Management of residual mass in nonseminomatous germ cell tumors following chemotherapy. Ther Adv Urol. 2011 Aug; 3(4):163-71. PMID: 21969846.
      View in: PubMed
    194. Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G, Nichols PW, Skinner DG, Skinner EC. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol. 2011 Nov; 60(5):946-52. PMID: 21802833.
      View in: PubMed
    195. Loh-Doyle JC, Patil MB, Daneshmand S. Renal cell carcinoma with inferior vena cava tumor thrombus and metastatic caval wall invasion. Urology. 2012 Feb; 79(2):e6-8. PMID: 21724242.
      View in: PubMed
    196. Zhuang L, Duty BD, Conlin MJ, Daneshmand S. Colocalycostomy for repair of ureterojejunal fistula. Urology. 2012 Feb; 79(2):e12-4. PMID: 21705047.
      View in: PubMed
    197. Daneshmand S, Bartsch G. Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Expert Rev Anticancer Ther. 2011 Jun; 11(6):941-8. PMID: 21707291.
      View in: PubMed
    198. Djaladat H, Nichols C, Daneshmand S. Androgen-producing testicular germ cell tumors. J Clin Oncol. 2011 Jul 20; 29(21):e634-5. PMID: 21606422.
      View in: PubMed
    199. Daneshmand S, Djaladat H, Porter CR, Nichols C. Evaluation and Preservation of Fertility in Patients with Testicular Cancer. J Adolesc Young Adult Oncol. 2011 Mar; 1(1):25-9. PMID: 26812566.
      View in: PubMed
    200. Daneshmand S. Editorial comment. Urology. 2010 Oct; 76(4):1001. PMID: 20932423.
      View in: PubMed
    201. Ashley MS, Daneshmand S. Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy. BJU Int. 2010 Sep; 106(5):654-7. PMID: 20089108.
      View in: PubMed
    202. Kollmannsberger C, Daneshmand S, So A, Chi KN, Murray N, Moore C, Hayes-Lattin B, Nichols C. Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery. J Clin Oncol. 2010 Feb 01; 28(4):537-42. PMID: 20026807.
      View in: PubMed
    203. Duty B, Daneshmand S. Resection of the inferior vena cava without reconstruction for urologic malignancies. Urology. 2009 Dec; 74(6):1257-62. PMID: 19819533.
      View in: PubMed
    204. Schreiner A, Daneshmand S, Bayne A, Countryman G, Corless CL, Troxell ML. Distinctive morphology of renal cell carcinomas in tuberous sclerosis. Int J Surg Pathol. 2010 Oct; 18(5):409-18. PMID: 19403547.
      View in: PubMed
    205. Ashley MS, Moneta G, Daneshmand S. Open partial nephrectomy for pediatric renovascular hypertension. ScientificWorldJournal. 2009 Apr 28; 9:287-90. PMID: 19412557.
      View in: PubMed
    206. Ashley MS, Daneshmand S. Re: Appendiceal substitution following right proximal ureter injury. Int Braz J Urol. 2009 Jan-Feb; 35(1):90-1. PMID: 19254404.
      View in: PubMed
    207. Daneshmand S. Words of wisdom. Re: use of androgen deprivation therapy for metastatic prostate cancer in older men. Eur Urol. 2008 Nov; 54(5):1201-2. PMID: 19051382.
      View in: PubMed
    208. Duty B, Daneshmand S. Venous resection in urological surgery. J Urol. 2008 Dec; 180(6):2338-42; discussion 2342. PMID: 18930288.
      View in: PubMed
    209. Wagner M, Bayne A, Daneshmand S. Application of the Yang-Monti channel in adult continent cutaneous urinary diversion. Urology. 2008 Oct; 72(4):828-31. PMID: 18674804.
      View in: PubMed
    210. Daneshmand S, Quek ML, Lin E, Lee C, Cote RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, Lee AS, Pinski J. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol. 2007 Oct; 38(10):1547-52. PMID: 17640713.
      View in: PubMed
    211. Wagner MD, Daneshmand S, Sokoloff M, Barry JM. Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403. J Urol. 2007 Jun; 177(6):2396; author reply 2396-7. PMID: 17509368.
      View in: PubMed
    212. Bayne A, Koslin B, Daneshmand S. Bilateral segmental testicular infarction. ScientificWorldJournal. 2007 Feb 19; 7:779-83. PMID: 17619760.
      View in: PubMed
    213. Dorff TB, Quek ML, Daneshmand S, Pinski J. Evolving treatment paradigms for locally advanced and metastatic prostate cancer. Expert Rev Anticancer Ther. 2006 Nov; 6(11):1639-51. PMID: 17134367.
      View in: PubMed
    214. Moore CJ, Daneshmand S, Kondagunta GV, Nichols CR. Management of difficult germ-cell tumors. Oncology (Williston Park). 2006 Nov; 20(12):1565-70, 1575; discussion 1575-6. PMID: 17153909.
      View in: PubMed
    215. Quek ML, Daneshmand S, Rodrigo S, Cai J, Dorff TB, Groshen S, Skinner DG, Lieskovsky G, Pinski J. Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer. Urology. 2006 Jun; 67(6):1247-52. PMID: 16697447.
      View in: PubMed
    216. Quek ML, Stein JP, Daneshmand S, Miranda G, Thangathurai D, Roffey P, Skinner EC, Lieskovsky G, Skinner DG. A critical analysis of perioperative mortality from radical cystectomy. J Urol. 2006 Mar; 175(3 Pt 1):886-9; discussion 889-90. PMID: 16469572.
      View in: PubMed
    217. Komanapalli CB, Tripathy U, Sokoloff M, Daneshmand S, Das A, Slater MS. Intraoperative renal cell carcinoma tumor embolization to the right atrium: incidental diagnosis by transesophageal echocardiography. Anesth Analg. 2006 Feb; 102(2):378-9. PMID: 16428527.
      View in: PubMed
    218. Daneshmand S, Quek ML. Adrenal myelolipoma: diagnosis and management. Urol J. 2006; 3(2):71-4. PMID: 17590837.
      View in: PubMed
    219. Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol. 2005 Jul; 174(1):103-6. PMID: 15947587.
      View in: PubMed
    220. Sokoloff MH, Daneshmand S, Ryan CW. Current clinical trials in renal cell carcinoma. Urol Oncol. 2005 Jul-Aug; 23(4):289-92. PMID: 16018946.
      View in: PubMed
    221. Quek ML, Nichols PW, Yamzon J, Daneshmand S, Miranda G, Cai J, Groshen S, Stein JP, Skinner DG. Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. J Urol. 2005 Jul; 174(1):93-6. PMID: 15947585.
      View in: PubMed
    222. Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS. EphB4 expression and biological significance in prostate cancer. Cancer Res. 2005 Jun 01; 65(11):4623-32. PMID: 15930280.
      View in: PubMed
    223. Daneshmand S, Dorff TB, Quek ML, Cai J, Pike MC, Nichols PW, Pinski J. Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue. Urology. 2005 May; 65(5):1008-12. PMID: 15882754.
      View in: PubMed
    224. Daneshmand S, Quek ML, Stein JP, Lieskovsky G, Cai J, Pinski J, Skinner EC, Skinner DG. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol. 2004 Dec; 172(6 Pt 1):2252-5. PMID: 15538242.
      View in: PubMed
    225. Quek ML, Sanderson KM, Daneshmand S, Stein JP. The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer. Expert Rev Anticancer Ther. 2004 Dec; 4(6):1007-16. PMID: 15606329.
      View in: PubMed
    226. Quek ML, Sanderson K, Daneshmand S, Stein JP. New molecular markers for bladder cancer detection. Curr Opin Urol. 2004 Sep; 14(5):259-64. PMID: 15300145.
      View in: PubMed
    227. Chandrasoma S, Moatamed N, Chang A, Daneshmand S, Ma Y. Angiomyolipoma of the kidney: expanding disease spectrum demonstrated by 3 cases. Appl Immunohistochem Mol Morphol. 2004 Sep; 12(3):277-83. PMID: 15551744.
      View in: PubMed
    228. Chandrasoma S, Daneshmand S, Wilson S, Skinner EC. Renal angiomyolipoma with liposarcomatous transformation: a case report and review of the literature. Urol Oncol. 2004 Sep-Oct; 22(5):425-7. PMID: 15464925.
      View in: PubMed
    229. Daneshmand S, Stein JP, Lesser T, Quek ML, Nichols PW, Miranda G, Cai J, Groshen S, Skinner EC, Skinner DG. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder. J Urol. 2004 Jul; 172(1):81-4. PMID: 15201742.
      View in: PubMed
    230. Daneshmand S. Adenomatous polyp of the verumontanum causing bladder outlet obstruction. ScientificWorldJournal. 2004 Jun 07; 4 Suppl 1:89-91. PMID: 15349532.
      View in: PubMed
    231. Daneshmand S, Chandrasoma S, Wilson S. Primary renal carcinoid tumor. ScientificWorldJournal. 2004 Jun 03; 4:378-80. PMID: 15311325.
      View in: PubMed
    232. Tchelepi H, Daneshmand S, Yanle Z, Ralls PW. Sonography of spermatic cord leiomyoma: case report and review of the literature. J Ultrasound Med. 2004 Apr; 23(4):569-71. PMID: 15098879.
      View in: PubMed
    233. Stein JP, Daneshmand S, Dunn M, Garcia M, Lieskovsky G, Skinner DG. Continent right colon reservoir using a cutaneous appendicostomy. Urology. 2004 Mar; 63(3):577-80; discussion 580-1. PMID: 15028464.
      View in: PubMed
    234. Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Cote RJ, Lieskovsky G, Quinn DI, Skinner DG. Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol. 2004 Feb; 171(2 Pt 1):640-5. PMID: 14713777.
      View in: PubMed
    235. Daneshmand S, Youssefzadeh D, Chamie K, Boswell W, Wu N, Stein JP, Boyd S, Skinner DG. Benign retroperitoneal schwannoma: a case series and review of the literature. Urology. 2003 Dec; 62(6):993-7. PMID: 14665342.
      View in: PubMed
    236. Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Lieskovsky G, Quinn DI, Raghavan D, Skinner DG. Natural history of surgically treated bladder carcinoma with extravesical tumor extension. Cancer. 2003 Sep 01; 98(5):955-61. PMID: 12942562.
      View in: PubMed
    237. Quek ML, Shpall AI, Daneshmand S. Colourachal fistula in an adult presenting with feculent umbilical drainage. J Urol. 2003 Jul; 170(1):184. PMID: 12796680.
      View in: PubMed
    238. Daneshmand S, Quek ML, Huffman JL. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer. 2003 Jul 01; 98(1):55-60. PMID: 12833455.
      View in: PubMed
    239. Quek ML, Quinn DI, Daneshmand S, Stein JP. Molecular prognostication in bladder cancer--a current perspective. Eur J Cancer. 2003 Jul; 39(11):1501-10. PMID: 12855255.
      View in: PubMed
    240. Daneshmand S, Chandrasoma S, Lum C. Sarcomatoid renal cell carcinoma with massive osteosarcomatous differentiation: an unusual image in clinical urology. Urology. 2003 May; 61(5):1031-2. PMID: 12736033.
      View in: PubMed
    241. Daneshmand S, Ginsberg DA, Bennet JK, Foote J, Killorin W, Rozas KP, Green BG. Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence. J Urol. 2003 Jan; 169(1):199-202. PMID: 12478135.
      View in: PubMed
    242. Daneshmand S, Huffman JL. Endoscopic management of renal hemangioma. J Urol. 2002 Feb; 167(2 Pt 1):488-9. PMID: 11792903.
      View in: PubMed
    243. Daneshmand S, Youssefzadeh D, Skinner EC. Review of techniques to remove a Foley catheter when the balloon does not deflate. Urology. 2002 Jan; 59(1):127-9. PMID: 11796297.
      View in: PubMed
    244. Shapiro BS, Richter KS, Harris DC, Daneshmand ST. Dramatic declines in implantation and pregnancy rates in patients who undergo repeated cycles of in vitro fertilization with blastocyst transfer after one or more failed attempts. Fertil Steril. 2001 Sep; 76(3):538-42. PMID: 11532478.
      View in: PubMed
    245. Buyalos RP, Ghosh K, Daneshmand ST. Infertile women of advanced reproductive age. Variability of day 3 FSH and E2 levels. J Reprod Med. 1998 Dec; 43(12):1023-6. PMID: 9883405.
      View in: PubMed